Park Capital Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
SP
CRM
SW
AWA
SFA
HPC
Park Capital Management's AMGN Position: Q2 2026 in Review
Park Capital Management increased its Amgen (AMGN) stake by 16% in Q2 2026, buying an estimated $45.9K and bringing the position to 978 shares worth $354K. The position accounts for 0.21% of the portfolio, ranked #78.
Park Capital Management first reported a position in AMGN in Q4 2024 and has held it in 7 quarters since. 577 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Park Capital Management held 978 shares of Amgen worth $354K as of Q2 2026.
- Park Capital Management bought 134 Amgen shares in Q2 2026, an estimated $45.9K.
- Amgen made up 0.21% of Park Capital Management's portfolio in Q2 2026, its #78 holding.
- Park Capital Management first reported a position in Amgen in Q4 2024 and has held it in 7 quarters since.
- 577 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Park Capital Management's 13F filing for Q2 2026, filed 13 Jul 2026.